Andrew Berens Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
108%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73.3%
Neutral
26.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $46 |
119%
upside
| 1 | -3.8% |
0
%
| 7 Jan ‘26 14 hours ago |
|
|
|
Outperform
Maintained
| $40 |
40%
upside
| 2 | +14% |
0
%
| 26 Dec ‘25 12 days ago |
|
|
|
Outperform
Maintained
| $149 |
39%
upside
| 2 | +19% |
0
%
| 17 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $50 |
38%
upside
| 2 | +120% |
0
%
| 10 Nov ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $15 |
80%
upside
| 1 | +30% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Market Perform
Downgraded
| $97 | – | 1 | – |
–
| 6 Oct ‘25 3 months ago |
|
|
|
Outperform
Initiated
| $25 |
107%
upside
| 1 | +21% |
0
%
| 17 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $60 |
45%
downside
| 1 | +693% |
0
%
| 28 Jul ‘25 5 months ago |
|
|
|
Market Perform
Downgraded
| $9 |
27%
downside
| 1 | – |
–
| 2 Jun ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $6 |
10%
upside
| 1 | +143% |
0
%
| 2 Apr ‘25 9 months ago |
|
|
|
Market Perform
Downgraded
| $1 |
174%
upside
| 1 | – |
–
| 21 Mar ‘25 9 months ago |
|
|
|
Market Perform
Maintained
| $762 |
6%
downside
| 1 | – |
–
| 28 Jan ‘25 11 months ago |
|